, Volume 62, Supplement 2, pp 53–61 | Cite as

Current Approaches to the Management of Smoking Cessation

Review Article


Smoking remains a widespread intractable behaviour and is a significant cause of morbidity and mortality worldwide. Effective approaches to smoking cessation include behavioural intervention and pharmacotherapy, in particular nicotine replacement therapy (NRT) and sustained-release bupropion (bupropion SR). Pharmacotherapy remains a popular choice of smoking cessation intervention for many smokers, and both NRT and bupropion SR, combined with behavioural interventions, achieve 1.5- to >2-fold increases in smoking cessation rates. Various national and international smoking cessation guidelines have been published recommending effective implementation of smoking cessation strategies. Recommendations include the systematic identification of smokers, assessment of their willingness to quit smoking, provision of advice promoting a cessation attempt, and administration of approved first-line therapies.


Nicotine Smoking Cessation Bupropion Nicotine Replacement Therapy Nicotine Patch 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.



G. Sutherland has received travel funds from, and undertaken research and consultancy for, manufacturers of nicotine replacement therapy and bupropion.


  1. 1.
    Eckert T, Junker C. Motivation for smoking cessation: what role do doctors play? Swiss Med Wkly 2001; 131: 521–6PubMedGoogle Scholar
  2. 2.
    Rigotti NA. Treatment of tobacco use and dependence. N Engl J Med 2000; 346(7): 506–12CrossRefGoogle Scholar
  3. 3.
    Raw M, McNeill A, West R. Smoking cessation guidelines for health professionals: a guide to effective smoking cessation interventions for the healthcare system. Thorax 1998; 53 Suppl 5(Pt 1): S1–19CrossRefGoogle Scholar
  4. 4.
    Lawrence WF, Smith SS, Baker TB, et al. Does over-the-counter nicotine replacement therapy improve smokers’ life expectancy? Tob Control 1998; 7: 364–8PubMedCrossRefGoogle Scholar
  5. 5.
    American College of Chest Physicians, American Thoracic Society, Asia Pacific Society of Respirology, et al. Smoking and health: physician responsibility. Chest 1995; 108(4): 1118–21CrossRefGoogle Scholar
  6. 6.
    Silagy C, Formica N. Place of bupropion in smoking-cessation therapy. Lancet 2001; 357: 1550PubMedCrossRefGoogle Scholar
  7. 7.
    Hughes JR, Gulliver SB, Fenwick JW, et al. Smoking cessation among self-quitters. Health Psychol 1992; 11(5): 331–5PubMedCrossRefGoogle Scholar
  8. 8.
    Rennard SI, Daughton DM. Smoking cessation. Chest 2000; 117(5): 360S–4SPubMedCrossRefGoogle Scholar
  9. 9.
    Fiore MC, Bailey WC, Cohen SJ, et al. Treating tobacco use and dependence: clinical practice guidelines. Rockville (MD): US Department of Health and Human Services. Public Health Service, 2000 JunGoogle Scholar
  10. 10.
    West R, McNeill A, Raw M. Smoking cessation guidelines for health professionals: an update. Thorax 2000; 55: 987–99PubMedCrossRefGoogle Scholar
  11. 11.
    Fiore MC, Pierce PJ, Remington PL, et al. Cigarette smoking: the clinician’s role in cessation, prevention, and public health. Dis Mon 1990; 36(4): 181–242PubMedCrossRefGoogle Scholar
  12. 12.
    Russell MAH, Wilson C, Taylor C, et al. Effects of general practitioners’ advice against smoking. BMJ 1979; 2(6184): 231–5PubMedCrossRefGoogle Scholar
  13. 13.
    Emmons KM. Smoking cessation and tobacco control: an overview. Chest 1999; 116: 490S–2SPubMedCrossRefGoogle Scholar
  14. 14.
    Fiore MC, Jorenby DE, Schensky AE, et al. Smoking status as a new vital sign: effects on assessment and intervention in patients who smoke. Mayo Clin Proc 1995; 70(3): 209–13PubMedCrossRefGoogle Scholar
  15. 15.
    Coleman T. Smoking cessation: integrating recent advances into clinical practice. Thorax 2001; 56: 579–82PubMedCrossRefGoogle Scholar
  16. 16.
    Lancaster T, Stead L, Silagy C, et al. Effectiveness of interventions to help people stop smoking: findings from the Cochrane Library. BMJ 2000; 321(5): 355–8PubMedCrossRefGoogle Scholar
  17. 17.
    Silagy C, Stead LF. Physician advice for smoking cessation (Cochrane Review). Available in The Cochrane Library [database on disk and CD ROM]. Updated quarterly. The Cochrane Collaboration; Issue 1. Oxford: Update Software, 2002Google Scholar
  18. 18.
    Rice VH, Stead LF. Nursing interventions for smoking cessation (Cochrane Review). Available in The Cochrane Library [database on disk and CD ROM]. Updated quarterly. The Cochrane Collaboration; Issue 1. Oxford: Update Software, 2002Google Scholar
  19. 19.
    World Health Organisation (WHO). European partnership to reduce tobacco dependence: WHO evidence based recommendations on the treatment of tobacco dependence. Geneva: WHO, 2001 JunGoogle Scholar
  20. 20.
    Butler CC, Pill R, Stott NCH. Qualitative study of patients’ perception of doctors advice to quit smoking: implications for opportunistic health promotion. BMJ 1998; 316: 1878–81PubMedCrossRefGoogle Scholar
  21. 21.
    Prochazka AV. New developments in smoking cessation. Chest 2000; 117(4): 169S–75SPubMedCrossRefGoogle Scholar
  22. 22.
    Coleman T, Wilson A. Managing smoking cessation: implementing new guidelines in primary care presents a challenge. BMJ 1999; 318: 138–9PubMedCrossRefGoogle Scholar
  23. 23.
    Fiore MC, Jorenby DE, Baker TB. Smoking cessation: principles and practice based upon the AHCPR Guidelines, 1996. Ann Behav Med 1997; 19(3): 213–9PubMedCrossRefGoogle Scholar
  24. 24.
    McEwen A, West R, Owen L. General practitioners’ views on the provision of nicotine replacement therapy and bupropion. BMC Fam Pract 2001;2: 6PubMedCrossRefGoogle Scholar
  25. 25.
    Lancaster T, Stead LF. Individual behavioural counselling for smoking cessation (Cochrane Review). Available in The Cochrane Library [database on disk and CD ROM]. Updated quarterly. The Cochrane Collaboration; Issue 1. Oxford: Update Software, 2002Google Scholar
  26. 26.
    Stead LF, Lancaster T. Group behaviour therapy programmes for smoking cessation (Cochrane Review). Available in The Cochrane Library [database on disk and CD ROM]. Updated quarterly. The Cochrane Collaboration; Issue 1. Oxford: Update Software, 2002Google Scholar
  27. 27.
    The Tobacco Use and Dependence Clinical Practice Guideline Panel, Staff, and Consortium Representatives. A clinical practice guideline for treating tobacco use and dependence. A US Public Health Service Report. JAMA 2000; 283(24): 3244–54CrossRefGoogle Scholar
  28. 28.
    Raw M, McNeill A, West R. Smoking cessation: evidence based recommendations for healthcare systems. BMJ 1999; 318: 182–5PubMedCrossRefGoogle Scholar
  29. 29.
    Lancaster T, Stead LF. Self-help interventions for smoking cessation (Cochrane Review). Available in The Cochrane Library [database on disk and CD ROM]. Updated quarterly. The Cochrane Collaboration; Issue 1. Oxford: Update Software, 2002Google Scholar
  30. 30.
    McElnay JC, Maguire TA, Drummond A, et al. Smoking cessation: the contribution of community pharmacy. Drugs 2000; 8(3): 147–58Google Scholar
  31. 31.
    Friedman RH, Stollerman JE, Mahoney DM, et al. The virtual visit: using telecommunications technology to take care of patients. J Am Med Inform Assoc 1997; 4(6): 413–25PubMedCrossRefGoogle Scholar
  32. 32.
    Platt S, Tannahill A, Watson J, et al. Effectiveness of antismoking telephone helpline: follow up survey. BMJ 1997; 314(7091): 1371–5PubMedCrossRefGoogle Scholar
  33. 33.
    Borland R, Segan CJ, Livingston PM, et al. The effectiveness of callback counselling for smoking cessation: a randomized trial. Addiction 2001; 96(6): 881–9PubMedCrossRefGoogle Scholar
  34. 34.
    Deagle EA, Berigan TR. Adding behavioral therapy to medication for smoking cessation. JAMA 1999; 281(21): 1983–9PubMedCrossRefGoogle Scholar
  35. 35.
    Jorenby DE. Smoking cessation strategies for the 21st century. Circulation 2001; 104: 51–2CrossRefGoogle Scholar
  36. 36.
    Lennox AS, Osman LM, Reiter E, et al. Cost effectiveness of computer tailored and non-tailored smoking cessation letters in general practice: randomised controlled trial. BMJ 2001; 322: 1–7CrossRefGoogle Scholar
  37. 37.
    Bock BC, Marcus BH, King TK, et al. Exercise effects on withdrawal and mood among women attempting smoking cessation. Addict Behav 1999; 24(3): 399–410PubMedCrossRefGoogle Scholar
  38. 38.
    Ussher MH, Taylor AH, West R, et al. Does exercise aid smoking cessation?: a systematic review. Addiction 2000; 95(2): 199–208PubMedCrossRefGoogle Scholar
  39. 39.
    White AR, Resch KL, Erns E. A meta-analysis of acupuncture techniques for smoking cessation. Tob Control 1999;8: 393–7PubMedCrossRefGoogle Scholar
  40. 40.
    Okuyemi KS, Ahluwalia JS, Harris KJ. Pharmacotherapy of smoking cessation. Arch Fam Med 2000; 9: 270–81PubMedCrossRefGoogle Scholar
  41. 41.
    Henningfield JE, Fant RV, Gitchell J, et al. Tobacco dependence: global public health potential for new medications development and indications. Ann NY Acad Sci 2000; 909: 247–56PubMedCrossRefGoogle Scholar
  42. 42.
    Silagy C, Lancaster T, Stead L, et al. Nicotine replacement therapy for smoking cessation (Cochrane Review). Available in The Cochrane Library [database on disk and CD ROM]. Updated quarterly. The Cochrane Collaboration; Issue 1. Oxford: Update Software, 2002Google Scholar
  43. 43.
    Bohadana A, Nilsson F, Rasmussen T, et al. Nicotine inhaler and nicotine patch as a combination therapy for smoking cessation: a randomized, double-blind, placebo-controlled trial. Arch Intern Med 2000; 160(20): 3128–34PubMedCrossRefGoogle Scholar
  44. 44.
    Hughes JR, Goldstein MG, Hurt RD, et al. Recent advances in the pharmacotherapy of smoking. JAMA 1999; 281(1): 72–6PubMedCrossRefGoogle Scholar
  45. 45.
    Abelin T, Ehrsam R, Buhler-Reichert A, et al. Effectiveness of a transdermal nicotine system in smoking cessation studies. Methods Find Exp Clin Pharmacol 1989; 11(3): 201–14Google Scholar
  46. 46.
    Bolliger CT, Zellweger JP, Danielsson T, et al. Smoking reduction with oral nicotine inhalers: double blind, randomised clinical trial of efficacy and safety. BMJ 2000; 321: 329–33PubMedCrossRefGoogle Scholar
  47. 47.
    Fiore MC, Smith SS, Jorenby DE, et al. The effectiveness of the nicotine patch for smoking cessation: a meta-analysis. JAMA 1994; 271(24): 1940–7PubMedCrossRefGoogle Scholar
  48. 48.
    Gourlay SG, Forbes A, Marriner T, et al. Prospective study of factors predicting outcome of transdermal nicotine treatment in smoking cessation. BMJ 1994; 309: 842–6PubMedCrossRefGoogle Scholar
  49. 49.
    Schneider NG, Olmstead R, Nilsson F, et al. Efficacy of a nicotine inhaler in smoking cessation: a double-blind, placebocontrolled trial. Addiction 1996; 91(9): 1293–306PubMedCrossRefGoogle Scholar
  50. 50.
    National Institute for Clinical Excellence (NICE). Guidance on the use of nicotine replacement therapy (NRT) and bupropion for smoking cessation. National Institute for Clinical Excellence Technology Appraisal Guidance No. 39, 2002 Apr. Available from URL: www.nice.org.uk
  51. 51.
    Daughton DM, Heatley SA, Prendergast JJ, et al. Effects of transdermal nicotine delivery as an adjunct to low intervention smoking cessation therapy: a randomized, placebo-controlled, double-blind study. Arch Intern Med 1991; 151(4): 749–52PubMedCrossRefGoogle Scholar
  52. 52.
    Herrera N, Franco R, Herrera L, et al. Nicotine Gum, 2 and 4mg, for nicotine dependence: a double-blind placebo-controlled trial within a behavior modification support program. Chest 1995; 108(2): 447–51PubMedCrossRefGoogle Scholar
  53. 53.
    Hurt RD, Dale LC, Fredrickson PA, et al. Nicotine patch therapy for smoking cessation combined with physician advice and nurse follow-up: one-year outcome and percentage of nicotine replacement. JAMA 1994; 271(8): 595–600PubMedCrossRefGoogle Scholar
  54. 54.
    Britton J, Jarvis MJ. Bupropion: a new treatment for smokers. Nicotine replacement treatment should also be available on the NHS. BMJ 2000; 321: 65–6PubMedCrossRefGoogle Scholar
  55. 55.
    Blondal T, Gudmundsson LJ, Olafsdottir I, et al. Nicotine nasal spray with nicotine patch for smoking cessation: randomized trial with six yearfollow up. BMJ 1999; 318: 285–9PubMedCrossRefGoogle Scholar
  56. 56.
    Kornitzer M, Boutsen M, Dramaix M, et al. Combined use of nicotine patch and gum in smoking cessation: a placebo-controlled clinical trial. Prev Med 1995; 24(1): 41–7PubMedCrossRefGoogle Scholar
  57. 57.
    Anda RF, Williamson DF, Escobedo LG, et al. Depression and the dynamics of smoking. JAMA 1990; 264(12): 1541–6PubMedCrossRefGoogle Scholar
  58. 58.
    Breslau N, Kilbey MM, Andreski P. Nicotine withdrawal symptoms and psychiatric disorders: findings from an epidemiologic study of young adults. Am J Psychiatry 1992; 149(4): 464–9PubMedGoogle Scholar
  59. 59.
    Breslau N, Kilbey MM, Andreski P. Nicotine dependence and major depression: new evidence from a prospective investigation. Arch Gen Psychiatry 1993; 50(1): 31–5PubMedCrossRefGoogle Scholar
  60. 60.
    Benowitz NL, Wilson Peng M. Non-nicotine pharmacotherapy for smoking cessation. Mechanisms and prospects. CNS Drugs 2000; 13(4): 265–85CrossRefGoogle Scholar
  61. 61.
    Barchas JD, Marzuk PM. General psychiatry. JAMA 1998; 280(11): 961–2PubMedCrossRefGoogle Scholar
  62. 62.
    Gambassi G, Bernabei R. Antidepressants and smoking cessation. Arch Intern Med 1999; 159: 1257–8PubMedCrossRefGoogle Scholar
  63. 63.
    Hurt RD, Sachs DPL, Glover ED, et al. A comparison of sustained-release bupropion and placebo for smoking cessation. N Engl J Med 1997; 337(17): 1195–202PubMedCrossRefGoogle Scholar
  64. 64.
    Covey LS, Sullivan MA, Johnston JA, et al. Advances in nonnicotine pharmacotherapy for smoking cessation. Drugs 2000; 59(1): 17–31PubMedCrossRefGoogle Scholar
  65. 65.
    Ferry LH, Burchette RJ. Efficacy of bupropion for smoking cessation in non-depressed smokers. J. Addict Dis 1994; 13: 249Google Scholar
  66. 66.
    Jorenby DE, Leischow SJ, Nides MA, et al. A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation. N Engl J Med 1999; 340(9): 685–91PubMedCrossRefGoogle Scholar
  67. 67.
    Hughes JR, Stead LF, Lancaster T. Antidepressants for smoking cessation (Cochrane Review). Available in The Cochrane Library [database on disk and CD ROM]. Updated quarterly. The Cochrane Collaboration; Issue 1. Oxford: Update Software,2002Google Scholar
  68. 68.
    Jarvis MJ, Powell S, Marsh H, et al. A meta-analysis of clinical studies confirms the effectiveness of bupropion SR (Zyban™) in smoking cessation [abstract]. Presented at the 7th Annual Conference of the Society for Research on Tobacco and Nicotine; 2001 Mar 23–25; Seattle (WA)Google Scholar
  69. 69.
    Hays JT, Hurt RD, Rigotti NA, et al. Sustained-release bupropion for pharmacological relapse prevention after smoking cessation: a randomized, controlled trial. Ann Intern Med 2001; 135(6): 423–33PubMedGoogle Scholar
  70. 70.
    Hertzberg MA, Moore SD, Feldman ME, et al. A preliminary study of bupropion sustained-release for smoking cessation in patients with chronic posttraumatic stress disorder. J Clin Psychopharmacol 2001; 21(1): 94–8PubMedCrossRefGoogle Scholar
  71. 71.
    Tashkin DP, Kanner R, Bailey W, et al. Smoking cessation in patients with chronic obstructive pulmonary disease: a double-blind, placebo-controlled, randomised trial. Lancet 2001; 357: 1571–5PubMedCrossRefGoogle Scholar
  72. 72.
    Coleman T, West R. Newly available treatments for nicotine addiction: smokers wanting help to stop smoking now have effective treatment options. BMJ 2001; 322: 1076–7PubMedCrossRefGoogle Scholar
  73. 73.
    Ascher JA, Cole JO, Colin JN, et al. Bupropion: a review of its mechanism of antidepressant activity. J Clin Psychiatry 1995; 56: 395–401PubMedGoogle Scholar
  74. 74.
    Holm KJ, Spencer CM. Bupropion: a review of its use in the management of smoking cessation. Drugs 2000; 59(4): 1007–24PubMedCrossRefGoogle Scholar
  75. 75.
    Rose JE, Behm FM, Westman EC. Nicotine-mecamylamine treatment for smoking cessation: the role of pre-cessation therapy. Exp Clin Psychopharmacol 1998; 6(3): 331–43PubMedCrossRefGoogle Scholar
  76. 76.
    Rose JE, Behm FM, Westman EC, et al. Mecamylamine combined with nicotine skin patch facilitates smoking cessation beyond nicotine patch treatment alone. Clin Pharmacol Ther 1994; 56(1): 86–99PubMedCrossRefGoogle Scholar
  77. 77.
    Glassman AH, Covey LS, Dalack GW, et al. Smoking cessation, clonidine, and vulnerability to nicotine among dependent smokers. Clin Pharmacol Ther 1993; 54(6): 670–9PubMedCrossRefGoogle Scholar
  78. 78.
    Glassman AH, Stetner F, Walsh BT, et al. Heavy smokers, smoking cessation, and clonidine: results of a double-blind, randomized trial. JAMA 1988; 259(19): 2863–6PubMedCrossRefGoogle Scholar
  79. 79.
    Hilleman DE, Mohiuddin SM, Delcore MG, et al. Randomized, controlled trial of transdermal clonidine for smoking cessation. Ann Pharmacother 1993; 27(9): 1025–8PubMedGoogle Scholar
  80. 80.
    Sutherland G, Stapleton J, Russell MAH, et al. Naltrexone, smoking behaviour and cigarette withdrawal. Psychopharmacology 1995; 120(4): 418–25PubMedCrossRefGoogle Scholar
  81. 81.
    Dwoskin LP, Crooks PA. A novel mechanism of action and potential use for lobeline as a treatment for psychostimulant abuse. Biochem Pharmacol 2002; 63(2): 89–98PubMedCrossRefGoogle Scholar
  82. 82.
    Hymowitz N, Eckholdt H. Effects of a 2.5-mg silver acetate lozenge on initial and long-term smoking cessation. Prev Med 1996; 25(5): 537–46PubMedCrossRefGoogle Scholar
  83. 83.
    West R, Willis N. Double-blind placebo controlled trial of dextrose tablets and nicotine patch in smoking cessation. Psychopharmacology 1998; 136(2): 201–4PubMedCrossRefGoogle Scholar
  84. 84.
    West R, Courts S, Beharry S, et al. Acute effect of glucose tablets on desire to smoke. Psychopharmacology 1999; 147(3): 319–21PubMedCrossRefGoogle Scholar
  85. 85.
    West R. Glucose for smoking cessation: does it have a role? CNS Drugs 2001; 15(4): 261–5PubMedCrossRefGoogle Scholar
  86. 86.
    Woolf SH, Grol R, Hutchinson A, et al. Potential benefits, limitations, and harms of clinical guidelines. BMJ 1999; 318: 527–30PubMedCrossRefGoogle Scholar
  87. 87.
    Fiore MC, Bailey WC, Cohen SJ, et al. Smoking cessation: clinical practice guidelines No 18. Rockville (MD): US Department of Health and Human Services. Public Health Service, Agency for Health Care Policy and Research, 1996. AHCPR publication no.: 96-0692Google Scholar
  88. 88.
    Practice guidelines for the treatment of patients with nicotine dependence. American Psychiatry Association. Available from URL: http//www.psych.org/clin_res/pg_nicotine.cfm [Accessed]
  89. 89.
    Smoking Kills. A White Paper on Tobacco. Available from URL: http://archive.oficial.document.co.uk/document/cm41/4177.htm
  90. 90.
    Silagy CA, Stead LF, Lancaster T. Use of systematic reviews in clinical practice guidelines: case study of smoking cessation. BMJ 2001 Oct; 323(7317): 833–6PubMedCrossRefGoogle Scholar
  91. 91.
    Anderson JE, Jorneby DE, Scott WJ, et al. Treating tobacco use and dependence: an evidence-based clinical practice guideline for tobacco cessation. Chest 2002; 121(3): 932–41PubMedCrossRefGoogle Scholar
  92. 92.
    Foulds J. Effectiveness of smoking cessation initiatives. BMJ 2002; 324: 608–9CrossRefGoogle Scholar

Copyright information

© Adis International Limited 2002

Authors and Affiliations

  1. 1.Tobacco Research SectionNational Addiction Centre, Institute of Psychiatry, Kings CollegeLondonUK

Personalised recommendations